OS Therapies Appoints Dr. Craig Eagle to Board of Directors
OS Therapies appointed Dr. Craig Eagle, former Chief Medical Officer of Guardant Health, to its Board of Directors and secured a $10 million line of credit backed by UK tax credits. The company confirmed consensus on key regulatory items for OST-HER2, targeting potential early market authorization in late 2026 and a Phase 3 initiation in late Q3.
Key figures
- Initial draw usd
- 1600000
- Line of credit usd
- 10000000
- Pending tax credits usd
- 5860000
- Expected tax credits 2026 usd
- 10200000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.